ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SUN Surgical Innovations Group Plc

0.50
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innovations Group Plc LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.50 0.40 0.60 0.50 0.50 0.50 164,510 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 11.34M 264k 0.0003 16.67 4.66M
Surgical Innovations Group Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker SUN. The last closing price for Surgical Innovations was 0.50p. Over the last year, Surgical Innovations shares have traded in a share price range of 0.40p to 2.25p.

Surgical Innovations currently has 932,816,000 shares in issue. The market capitalisation of Surgical Innovations is £4.66 million. Surgical Innovations has a price to earnings ratio (PE ratio) of 16.67.

Surgical Innovations Share Discussion Threads

Showing 9701 to 9723 of 11925 messages
Chat Pages: Latest  393  392  391  390  389  388  387  386  385  384  383  382  Older
DateSubjectAuthorDiscuss
22/1/2016
20:37
Company is in the best position, that it's been in for a long time. Management in place, debt down and hopefully a long term future.
bjfanc
21/1/2016
22:42
an encouraging rns
argyle underclap
21/1/2016
09:47
The start of a new beginning
bashor
21/1/2016
09:13
Getting rid of the remaining dead wood imo !
gbh2
21/1/2016
09:10
Would be interested to know if Doug is leaving of his own accord or was pushed, and if so by whom ? Presume he has to take some of the blame for recent past performance albeit at last years AGM both he and Chris Rea were very keen to place the blame on the old MD Graham Bowland ! Also who has identified and engaged the 2 new non exec's ?
leadingladies
21/1/2016
07:11
Good, positive RNS this morning. Looks like we do still have a business here going forward. Pity I sold most of my shares and reinvested elsewhere - may buy some back now. share price should rise on this.
kenone
16/12/2015
08:15
Or the disgraced CEO cashing in some of his ill gotten shares?
gbh2
16/12/2015
07:21
CR taking some of his capital back?
mandate
15/12/2015
19:01
I see the trade at 13.26 and the reason for the fall today.
bjfanc
15/12/2015
17:21
What on earth is going on ?!? 2,000,000 sell after hrs at 1.35 p !
leadingladies
11/12/2015
21:22
A decent broker should be able to pitch this, as a recovery story. Bringing on board institutions, as hopefully SUN grows and re capitalises over the coming years.
bjfanc
11/12/2015
11:22
Very encouraging.
gnnmartin
11/12/2015
08:55
Really pleased Melanie Ross has agreed to withdraw her notice and stay on. I met her at the AGM and certainly got the impression she cared and was working hard to help turn the business around. I presume she still has a strong relationship with Chris Rea and will therefore help to protect his interests i.e. 66m shares as well as ours. First bit of good news I've had this week on the share front !!
leadingladies
11/12/2015
08:19
Positive update
jmf69
09/12/2015
22:28
Next time your doctor offers you anti-biotics



‘Post-antibiotic era’ looms amid unregulated drugs market – UK govt review
Published time: 20 Nov, 2015 15:04

Unregulated antibiotic sales in pharmacies and online are fueling the rise of deadly “superbug̶1; bacteria as the world sits on the cusp of an “antibiotic apocalypse,” according to a UK government-commissioned report.

Antibiotics can only be obtained by a doctor’s prescription in the UK, but it is relatively commonplace in many low- and middle-income countries for the drugs to be bought over the counter.

The report published on Friday urges governments, regulators and online firms to clamp down on unlicensed sales of antibiotics.

It comes amid global alarm about the discovery in China of a gene that makes bacteria resistant to even the strongest available antibiotic, prompting some scientists to warn the world is on the cusp of a ‘post-antibiotic era.’

In the government-commissioned report, former Goldman Sachs chief economist Jim O’Neill said the global threat is exacerbated by patients self-medicating with drugs from online pharmacies.

“Even in those countries where it’s next to impossible to buy antibiotics over-the-counter in a shop, it’s still often the case that an unscrupulous online pharmacy is just a few clicks away,” he said in a statement.

“These internet drug stores could be based anywhere in the world, so it’s vital that regulators – along with the industry, customs organizations and internet companies – work together to crack down.”

O’Neill said over-the-counter sales of antibiotics “remains relatively commonplace in Southern and Eastern Europe and many low- and middle-income countries.”

Overmedication and misuse of antibiotics is a major contributor to the evolution of bacteria resistance.

It is thought the overuse of colistin – the drug of last resort – in farm animals led to the creation of the world’s first completely antibiotic-resistant bacteria which was discovered in China.

The new mutation, dubbed the MCR-1 gene, may have already spread to Laos and Malaysia.

Professor Timothy Walsh of the University of Cardiff’s Institute of Infection & Immunity told the BBC the world is on the cusp of the “post-antibiotic era.”

“All the key players are now in place to make the post-antibiotic world a reality,” he said.

“If MCR-1 becomes global, which is a case of when not if, and the gene aligns itself with other antibiotic resistance genes, which is inevitable, then we will have very likely reached the start of the post-antibiotic era.

“At that point if a patient is seriously ill, say with E. coli, then there is virtually nothing you can do,” he added.

buywell2
22/11/2015
09:03
Been a while since I held these, looking interesting again, but how trustworthy is its future??
frequentbuyer
10/11/2015
14:33
Jury's out on that, imo it's down to how much do you trust the top management of any AIM company, in this case I don't know enough about them to judge so I'll be out at the next "news" drop if it doesn't provide some solid information.
gbh2
10/11/2015
14:22
Nice, but still high risk I'm guessing
bashor
10/11/2015
14:04
57% gain in two weeks :))
gbh2
10/11/2015
13:51
AIM and money spinner, I've never hit that sweet spot yet
bashor
10/11/2015
13:19
I was tempted at just over a penny, but found another AIM money spinner so I'll wish you good luck with this.
gbh2
10/11/2015
12:25
Just dipped my toe back in for a punt earlier, I will never learn

The trade at 1.8p for 165,769 was a buy much earlier in the day, so its not a sell as its showing in most places

bashor
07/11/2015
09:24
My assumptions are that Nigel Rogers has been bought into build the necessary management team. Similarly to what he did at 600 group.My other assumption is that Chris Rea wanted or needed to spend more time at his main company AESSEAL. Given all the cap ex cuts in the oil/mining industries. He also mentions SUN being a distraction in a Yorkshire post article from earlier in the year.My other assumption is that there is value in the relationship with AMS.But all difficult to quantify given the limited information provided. I continue to hold.
bjfanc
Chat Pages: Latest  393  392  391  390  389  388  387  386  385  384  383  382  Older

Your Recent History

Delayed Upgrade Clock